Screener
Fennec Pharmaceuticals FENC Q4 2025 Annual earnings
Reported March 24, 2026 · Before market open
Revenue$13.8MMiss by $855.2K
EPS-$0.11Miss by $0.14
Revenue estimate$14.7M
EPS estimate$0.03
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Fennec Pharmaceuticals report Q4 2025 earnings?
- Fennec Pharmaceuticals (FENC) reported Q4 2025 earnings on March 24, 2026 before market open.
- What were Fennec Pharmaceuticals's Q4 2025 revenue and EPS?
- Fennec Pharmaceuticals reported revenue of $13.8M and eps of $-0.11 for Q4 2025.
- Did Fennec Pharmaceuticals beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $14.7M by $855.2K. EPS missed the consensus estimate of $0.03 by $0.14.
- How did Fennec Pharmaceuticals's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 74.3% from $7.9M a year earlier and eps declined 83.3% from $-0.06.
- Where can I find Fennec Pharmaceuticals's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-26-033885) and the 10-K periodic report (0001104659-26-036182) directly on SEC EDGAR. The filing index links above go to sec.gov.
